Condition: Nodule Solitary Pulmonary · Non-small Cell Lung Cancer · Sponsor: University of California, San Francisco
This is a prospective observational study that will follow patients who undergo lung cancer screening at the San Francisco VA Medical Center, University of California, San Francisco (UCSF) Medical Center, and the San Francisco General Hospital. The proposed study will comprise of two primary populations to determine the ctDNA assay performance in a variety of clinical settings.
This description comes directly from the study's public registry record.
Mehrdad Arjomandi, MD · 877-827-3222 · cancertrials@ucsf.edu
Always discuss trial participation with your own doctor first.
| Zuckerberg San Francisco General Hospital and Trauma Center | San Francisco, California, United States | Recruiting |
| San Francisco VA Medical Center | San Francisco, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03774758